Transcriptomic studies identify Pax7 target gene repression to be a prominent feature of FSHD skeletal muscles, and may be a superior biomarker than the DUX4 target gene signature in terms of discriminating FSHD-affected muscle cells from healthy ones [79,80]. Here, PAX7 is linked to facioscapulohumeral muscular dystrophy.